BackLifevantage Overview
Lifevantage Corporation

Lifevantage Target Price

See Lifevantage's analyst price targets ($6) vs the current share price.

Get informed when a big investor buys or sells

+ Follow

Share Price

$6.07

Average Target Price

$6.001.2% downside

1 analysts in the last 4 months

High: $6 | Low: $6

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-28Lake StreetRyan Meyers$61.2% downsideOpen
2026-02-05Loop Capital MarketsBrooks O'Neil$517.6% downsideOpen
2026-02-05Lake Street$517.6% downsideOpen
2025-11-05Lake StreetRyan Meyers$1297.7% upsideOpen
2025-01-14Craig-HallumAlex Fuhrman$35476.6% upsideOpen
2025-01-10Lake StreetBrooks O'Neil$30394.2% upsideOpen
2024-12-19Lake StreetBrooks O'Neil$26328.3% upsideOpen

Lifevantage (LFVN) FAQ

Lifevantage (LFVN) currently reports a target price of $6. Use the charts on this page to explore Lifevantage's target price history and peer comparisons.

Analysts' average 12-month price target for Lifevantage is $6, about 1.2% downside from the current share price of $6.07. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $6, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Lifevantage, and consider following LFVN for alerts when major investors trade the stock.

Lifevantage is classified in the Healthcare sector. On target price, it currently shows $6. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LFVN with unrelated industries.